haematology
Research

News in Brief: Monash researchers target gene variant for Sickle Cell Disease cure; ABO Blood Group linked to COVID-19 risk; High thrombotic events with CDK 4/6 inhibitors for breast cancer

Monash researchers target gene variant for Sickle Cell Disease cure A cure for sickle cell disease (SCD) may be possible from gene-editing that targets mutations in Krüppel-like factor 1 (KLF1) expression – a pathway linked to the switch from foetal haemoglobin (HbF) to adult haemoglobin (HbA) formation, Australian researchers say. Researchers from Monash University were ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic